Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-018261

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 2, 2017P100,000$34.6384A3,291,165IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses